Bcl-2-family proteins and the role of mitochondria in apoptosis

Current Opinion in Cell Biology

Volumn 15, Issue 6, 2003, Pages 691-699

  Kuwana, Tomomi ^a   Newmeyer, Donald D ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CASPASE; CYTOCHROME C; ENDONUCLEASE; MEMBRANE PROTEIN; PROTEIN AIF; PROTEIN BCL 2; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; UNCLASSIFIED DRUG;

APOPTOSIS; CALCIUM TRANSPORT; CELL DEATH; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HUMAN; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0345276414     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2003.10.004     Document Type: Review

References (94)

1. van Loo G., Saelens X., van Gurp M., MacFarlane M., Martin S.J., Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 9:2002;1031-1042.
2. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1999;1899-1911.
3. Vander Heiden M.G. Thompson CB: Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat. Cell Biol. 1:1999;E209-E216.
4. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 39:2003;615-647.
5. Green D.R., Evan G.I. A matter of life and death. Cancer Cell. 1:2002;19-30.
6. Newmeyer D.D., Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell. 112:2003;481-490.
7. Krammer P.H. CD95's deadly mission in the immune system. Nature. 407:2000;789-795.
8. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
9. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
10. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
11. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
12. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.-I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
13. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
14. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
15. Yin X.M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B., Roth K.A., Korsmeyer S.J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 400:1999;886-891.
16. Kuwana T., Smith J.J., Muzio M., Dixit V., Newmeyer D.D., Kornbluth S. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J. Biol. Chem. 273:1998;16589-16594.
17. Fulda S., Meyer E., Debatin K.M. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene. 21:2002;2283-2294.
18. Deng Y., Lin Y., Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 16:2002;33-45.
19. Li S., Zhao Y., He X., Kim T.H., Kuharsky D.K., Rabinowich H., Chen J., Du C., Yin X.M. Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J. Biol. Chem. 277:2002;26912-26920.
20. Du C., Fang M., Li Y., Li L., Wang X. Smac, a mitochondrial protein that promotes cytochrome-c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:2000;33-42.
21. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., Vaux D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 102:2000;43-53.
22. Yang Q.H., Church-Hajduk R., Ren J., Newton M.L., Du C. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev. 17:2003;1487-1496.
23. Cilenti L., Lee Y., Hess S., Srinivasula S., Park K.M., Junqueira D., Davis H., Bonventre J.V., Alnemri E.S., Zervos A.S. Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2. J. Biol. Chem. 278:2003;11489-11494.
24. Martins L.M., Iaccarino I., Tenev T., Gschmeissner S., Totty N.F., Lemoine N.R., Savopoulos J., Gray C.W., Creasy C.L., Dingwall C., Downward J. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 277:2002;439-444.
25. Li L.Y., Luo X., Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 412:2001;95-99.
26. Lorenzo H.K., Susin S.A., Penninger J., Kroemer G. Apoptosis-inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 6:1999;516-524.
27. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
28. Wei M.C., Lindsten T., Mootha V.K., Weiler S., Gross A., Ashiya M., Thompson C.B., Korsmeyer S.J. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14:2000;2060-2071.
29. Lindsten T., Ross A.J., King A., Zong W.X., Rathmell J.C., Shiels H.A., Ulrich E., Waymire K.G., Mahar P., Frauwirth K., et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell. 6:2000;1389-1399.
30. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Pro-apoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death. Science. 292:2001;727-730.
31. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., Korsmeyer S.J. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8:2001;705-711.
32. L, thus de-repressing Bax and Bak. Although this is a provocative observation, a potential problem is that negative results with synthetic peptides could simply reflect a lack of the molecular constraints present in the full-length protein.
33. L, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
34. Chou J.J., Li H., Salvesen G.S., Yuan J., Wagner G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell. 96:1999;615-624.
35. McDonnell J.M., Fushman D., Milliman C.L., Korsmeyer S.J., Cowburn D. Solution structure of the pro-apoptotic molecule Bid: a structural basis for apoptotic agonists and antagonists. Cell. 96:1999;625-634.
36. Suzuki M., Youle R.J., Tjandra N. Structure of Bax. Co-regulation of dimer formation and intracellular localization. Cell. 103:2000;645-654.
37. Hinds M.G., Lackmann M., Skea G.L., Harrison P.J., Huang D.C., Day C.L. The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J. 22:2003;1497-1507.
38. Denisov A.Y., Madiraju M.S., Chen G., Khadir A., Beauparlant P., Attardo G., Shore G.C., Gehring K. Solution structure of human Bcl-w: modulation of ligand binding by the C-terminal helix. J. Biol. Chem. 278:2003;21124-21128.
39. Huang D.C., Strasser A. BH3-only proteins-essential initiators of apoptotic cell death. Cell. 103:2000;839-842.
40. Zha J., Weiler S., Oh K.J., Wei M.C., Korsmeyer S.J. Posttranslational N-myristoylation of Bid as a molecular switch for targeting mitochondria and apoptosis. Science. 290:2000;1761-1765.
41. Bouillet P., Purton J.F., Godfrey D.I., Zhang L.C., Coultas L., Puthalakath H., Pellegrini M., Cory S., Adams J.M., Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415:2002;922-926.
42. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Kontgen F., Adams J.M., Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1999;1735-1738.
43. Putcha G.V., Moulder K.L., Golden J.P., Bouillet P., Adams J.A., Strasser A., Johnson E.M. Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron. 29:2001;615-628.
44. Puthalakath H., Villunger A., O'Reilly L.A., Beaumont J.G., Coultas L., Cheney R.E., Huang D.C., Strasser A. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science. 293:2001;1829-1832.
45. Puthalakath H., Huang D.C., O'Reilly L.A., King S.M., Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell. 3:1999;287-296.
46. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 288:2000;1053-1058.
47. Nakano K., Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 7:2001;683-694.
48. Yu J., Zhang L., Hwang P.M., Kinzler K.W., Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell. 7:2001;673-682.
49. Inohara N., Ding L., Chen S., Nunez G. Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J. 16:1997;1686-1694.
50. Imaizumi K., Morihara T., Mori Y., Katayama T., Tsuda M., Furuyama T., Wanaka A., Takeda M., Tohyama M. The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein. J. Biol. Chem. 274:1999;7975-7981.
51. Imaizumi K., Tsuda M., Imai Y., Wanaka A., Takagi T., Tohyama M. Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death. J. Biol. Chem. 272:1997;18842-18848.
52. Minn A.J., Velez P., Schendel S.L., Liang H., Muchmore S.W., Fesik S.W., Fill M., Thompson C.B. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature. 385:1997;353-357.
53. Antonsson B., Conti F., Ciavatta A., Montessuit S., Lewis S., Martinou I., Bernasconi L., Bernard A., Mermod J.J., Mazzei G., et al. Inhibition of Bax cannel-forming activity by Bcl-2. Science. 277:1997;370-372.
54. Schendel S.L., Xie Z., Montal M.O., Matsuyama S., Montal M., Reed J.C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. U.S.A. 94:1997;5113-5118.
55. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 399:1999;483-487.
56. Saito M., Korsmeyer S.J., Schlesinger P.H. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat. Cell Biol. 2:2000;553-555.
57. L, decreases the lifetime of planar phospholipid bilayer membranes at subnanomolar concentrations. Proc. Natl. Acad. Sci. U.S.A. 96:1999;5492-5497.
58. L that were effective on whole mitochondria. Permeabilization required the concerted action of tBid and Bax, as well as the presence of the lipid cardiolipin in the membrane. Very large dextran molecules were released both from outer membrane vesicles and the liposomes, suggesting a supramolecular lipid-based pore. Liposomes now comprise an experimental system that can begin to address the detailed mechanism of mitochondrial outer membrane permeabilization in apoptosis.
59. Zong W.X., Lindsten T., Ross A.J., MacGregor G.R., Thompson C.B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15:2001;1481-1486.
60. Epand R.F., Martinou J.C., Montessuit S., Epand R.M., Yip C.M. Direct evidence for membrane pore formation by the apoptotic protein Bax. Biochem. Biophys. Res. Commun. 298:2002;744-749.
61. Desagher S., Osen-Sand A., Nichols A., Eskes R., Montessuit S., Lauper S., Maundrell K., Antonsson B., Martinou J.C. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144:1999;891-901.
62. Antonsson B., Montessuit S., Sanchez B., Martinou J.C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276:2001;11615-11623.
63. ••]) not in liposomes formed from extracted mitochondrial lipids However, they observe that proteoliposomes reconstituted with mitochondrial outer membrane proteins do respond to tBid and Bax. Hence, they conclude that at least one unidentified mitochondrial protein is also required for Bid/Bax-mediated permeabilization.
64. Basanez G., Sharpe J.C., Galanis J., Brandt T.B., Hardwick J.M., Zimmerberg J. Bax-type apoptotic proteins porate pure lipid bilayers through a mechanism sensitive to intrinsic monolayer curvature. J. Biol. Chem. 277:2002;49360-49365 The authors test the hypothesis that curvature stress in a membrane is important for Bax-induced permeabilization. In particular, they show that the addition of nonlamellar lipids (lipids that change the intrinsic curvature of the membrane) to liposomes can affect the ability of detergent-oligomerized Bax to form pores that allow the release of a fluorescent dye or cytochrome c.
65. Lutter M., Fang M., Luo X., Nishijima M., Xie X.-s., Wang X. Cardiolipin provides specificity for targeting of tBID to mitochondria. Nat. Cell Biol. 2:2000;754-756.
66. Perkins G., Renken C., Martone M.E., Young S.J., Ellisman M., Frey T. Electron tomography of neuronal mitochondria: three-dimensional structure and organization of cristae and membrane contacts. J. Struct. Biol. 119:1997;260-272.
67. L act by sequestering BH3-only proteins, such as tBid.
68. ••].
69. 2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J. 20:2001;2690-2701.
70. 2+ stores.
71. 2+ concentration within the endoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 97:2000;5723-5728.
72. Pinton P., Ferrari D., Magalhaes P., Schulze-Osthoff K., Di Virgilio F., Pozzan T., Rizzuto R. Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells. J. Cell Biol. 148:2000;857-862.
73. Vanden Abeele F., Skryma R., Shuba Y., Van Coppenolle F., Slomianny C., Roudbaraki M., Mauroy B., Wuytack F., Prevarskaya N. Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell. 1:2002;169-179.
74. Nakamura K., Bossy-Wetzel E., Burns K., Fadel M.P., Lozyk M., Goping I.S., Opas M., Bleackley R.C., Green D.R., Michalak M. Changes in endoplasmic reticulum luminal environment affect cell sensitivity to apoptosis. J. Cell Biol. 150:2000;731-740.
75. 2+ mobilization promotes cytochrome c release during apoptosis. J. Biol. Chem. 277:2002;20301-20308.
76. Zamzami N., Susin S.A., Marchetti P., Hirsch T., Gomez-Monterrey I., Castedo M., Kroemer G. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1996;1533-1544.
77. Marzo I., Brenner C., Zamzami N., Susin S.A., Beutner G., Brdiczka D., Remy R., Xie Z.H., Reed J.C., Kroemer G. The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2-related proteins. J. Exp. Med. 187:1998;1261-1271.
78. Bossy-Wetzel E., Newmeyer D.D., Green D.R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37-49.
79. 2+ ions. J. Cell Biol. 143:1998;217-224.
80. Goldstein J.C., Waterhouse N.J., Juin P., Evan G.I., Green D.R. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2:2000;156-162.
81. Szalai G., Krishnamurthy R., Hajnoczky G. Apoptosis driven by IP(3)-linked mitochondrial calcium signals. EMBO J. 18:1999;6349-6361.
82. Csordas G., Madesh M., Antonsson B., Hajnoczky G. tcBid promotes Ca(2+) signal propagation to the mitochondria: control of Ca(2+) permeation through the outer mitochondrial membrane. EMBO J. 21:2002;2198-2206.
83. Scorrano L., Ashiya M., Buttle K., Weiler S., Oakes S.A., Mannella C.A., Korsmeyer S.J. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell. 2:2002;55-67.
84. Waterhouse N.J., Goldstein J.C., von Ahsen O., Schuler M., Newmeyer D.D., Green D.R. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J. Cell Biol. 153:2001;319-328.
85. Ricci J.E., Gottlieb R.A., Green D.R. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell Biol. 160:2003;65-75 The authors show that, following mitochondrial outer membrane permeabilization, caspases cleave key substrates in complexes I and II of the electron transport chain, inhibiting respiration, reducing the mitochondrial membrane potential and generating reactive oxygen species. Together with the papers by Bossy-Wetzel et al., Goldstein et al., and Waterhouse et al., these authors reach a consistent conclusion that, in several forms of apoptosis, the loss of mitochondrial membrane potential is a caspase-induced event downstream of cytochrome c release, and not the result of permeability transition.
86. Miller T.M., Moulder K.L., Knudson C.M., Creedon D.J., Deshmukh M., Korsmeyer S.J., Johnson E.M. Jr. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol. 139:1997;205-217.
87. McCarthy N.J., Whyte M.K., Gilbert C.S., Evan G.I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:1997;215-227.
88. Hong X., Lei L., Glas R. Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis. J. Exp. Med. 197:2003;1731-1743.
89. Chautan M., Chazal G., Cecconi F., Gruss P., Golstein P. Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr. Biol. 9:1999;967-970.
90. von Ahsen O., Renken C., Perkins G., Kluck R.M., Bossy-Wetzel E., Newmeyer D.D. Preservation of mitochondrial structure and function after Bid- or Bax-mediated cytochrome c release. J. Cell Biol. 150:2000;1027-1036.
91. Mootha V.K., Wei M.C., Buttle K.F., Scorrano L., Panoutsakopoulou V., Mannella C.A., Korsmeyer S.J. A reversible component of mitochondrial respiratory dysfunction in apoptosis can be rescued by exogenous cytochrome c. EMBO J. 20:2001;661-671.
92. Moncada S., Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell Biol. 3:2002;214-220.
93. Fantin V.R., Berardi M.J., Scorrano L., Korsmeyer S.J., Leder P. A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. Cancer Cell. 2:2002;29-42.
94. Mathiasen I.S., Jaattela M. Triggering caspase-independent cell death to combat cancer. Trends Mol. Med. 8:2002;212-220.